|
End-of-day quote
Buenos Aires S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 1,440.00 ARS | -4.64% |
|
-7.69% | -27.09% |
| Market Cap | 116B 76.27M 67.08M 63.43M 57.53M 108M 7.32B 109M 759M 293M 3.74B 286M 280M 12B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 347B 228M 200M 189M 172M 323M 21.87B 325M 2.27B 876M 11.16B 855M 837M 35.86B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -4.64% | ||
| 1 week | -7.69% | ||
| Current month | -10.56% | ||
| 1 month | -8.28% | ||
| 3 months | -10.00% | ||
| 6 months | -11.66% | ||
| Current year | -27.09% |
| 1 week | 1,360 | 1,590 | |
| 1 month | 1,360 | 1,635 | |
| Current year | 1,360 | 2,130 | |
| 1 year | 975 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 2025-04-28 | |
| Corporate Officer/Principal | - | 2025-04-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.64% | -7.69% | +39.81% | +187.43% | 76.27M | ||
| +0.11% | +1.71% | +63.52% | +117.61% | 1,056B | ||
| +0.27% | +0.92% | +51.33% | +73.35% | 655B | ||
| +0.73% | +0.68% | +20.70% | +74.90% | 471B | ||
| -0.32% | -2.69% | +38.34% | +41.47% | 342B | ||
| +0.40% | +4.64% | +23.03% | +29.82% | 277B | ||
| +1.99% | +0.44% | +14.79% | +14.65% | 257B | ||
| +0.85% | +6.35% | +53.17% | +54.39% | 226B | ||
| +0.85% | +1.10% | +35.78% | +101.82% | 189B | ||
| +0.09% | -2.30% | -28.07% | -60.73% | 170B | ||
| Average | -0.06% | +0.02% | +31.24% | +63.47% | 364.3B | |
| Weighted average by Cap. | +0.17% | +1.04% | +40.57% | +69.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 60.2M 52.95M 50.07M 45.41M 85.29M 5.78B 85.79M 600M 232M 2.95B 226M 221M 9.48B | 127B 83.12M 73.1M 69.12M 62.7M 118M 7.98B 118M 828M 320M 4.07B 312M 305M 13.08B |
| Net income | 23.85B 15.64M 13.75M 13.01M 11.8M 22.16M 1.5B 22.28M 156M 60.15M 766M 58.72M 57.44M 2.46B | 3.09B 2.03M 1.78M 1.68M 1.53M 2.87M 194M 2.89M 20.17M 7.79M 99.2M 7.6M 7.44M 319M |
| Net Debt | 134B 87.65M 77.09M 72.9M 66.12M 124M 8.41B 125M 873M 337M 4.29B 329M 322M 13.8B | 231B 152M 133M 126M 114M 215M 14.55B 216M 1.51B 583M 7.42B 569M 557M 23.85B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | ARS 1,440.00 | -4.64% | 5,318 |
| 26-09-25 | ARS 1,510.00 | 0.00% | 2,196 |
| 26-09-24 | ARS 1,510.00 | -0.66% | 10,447 |
| 26-09-23 | ARS 1,520.00 | -3.49% | 7,769 |
| 26-09-22 | ARS 1,575.00 | +0.96% | 349 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















